SE457055B - Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser - Google Patents

Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser

Info

Publication number
SE457055B
SE457055B SE8603481A SE8603481A SE457055B SE 457055 B SE457055 B SE 457055B SE 8603481 A SE8603481 A SE 8603481A SE 8603481 A SE8603481 A SE 8603481A SE 457055 B SE457055 B SE 457055B
Authority
SE
Sweden
Prior art keywords
vasopressin
mucosa
radiation protection
tglvp
gel
Prior art date
Application number
SE8603481A
Other languages
English (en)
Swedish (sv)
Other versions
SE8603481L (sv
SE8603481D0 (sv
Inventor
K F Aronsen
G Nylander
S Borgstroem
Original Assignee
Ferring Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Ab filed Critical Ferring Ab
Priority to SE8603481A priority Critical patent/SE457055B/sv
Publication of SE8603481D0 publication Critical patent/SE8603481D0/xx
Priority to EP87850244A priority patent/EP0265400B1/fr
Priority to DE8787850244T priority patent/DE3770753D1/de
Priority to PCT/SE1987/000359 priority patent/WO1988001163A1/fr
Priority to JP62504940A priority patent/JPH02500668A/ja
Priority to AU78528/87A priority patent/AU609417B2/en
Priority to AT87850244T priority patent/ATE64308T1/de
Priority to IL83566A priority patent/IL83566A/xx
Publication of SE8603481L publication Critical patent/SE8603481L/
Priority to NO881580A priority patent/NO881580L/no
Priority to DK206688A priority patent/DK206688A/da
Publication of SE457055B publication Critical patent/SE457055B/sv
Priority to FI890715A priority patent/FI890715A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Colloid Chemistry (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Support Of Aerials (AREA)
  • Details Of Aerials (AREA)
SE8603481A 1986-08-18 1986-08-18 Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser SE457055B (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE8603481A SE457055B (sv) 1986-08-18 1986-08-18 Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser
AT87850244T ATE64308T1 (de) 1986-08-18 1987-08-14 Topisches gel zum schutz von schleimhaeuten bei bestrahlungen.
JP62504940A JPH02500668A (ja) 1986-08-18 1987-08-14 粘膜用局部的放射線防護ゲル
DE8787850244T DE3770753D1 (de) 1986-08-18 1987-08-14 Topisches gel zum schutz von schleimhaeuten bei bestrahlungen.
PCT/SE1987/000359 WO1988001163A1 (fr) 1986-08-18 1987-08-14 Gel radioprotecteur topique pour les muqueuses
EP87850244A EP0265400B1 (fr) 1986-08-18 1987-08-14 Gel topique radio protectif pour muqueuses
AU78528/87A AU609417B2 (en) 1986-08-18 1987-08-14 Topical radioprotective gel for mucosa
IL83566A IL83566A (en) 1986-08-18 1987-08-17 Radioprotective gel containing vasoconstrictors for topical application on mucosa
NO881580A NO881580L (no) 1986-08-18 1988-04-12 Lokal straalingsbeskyttende gel for slimhinne.
DK206688A DK206688A (da) 1986-08-18 1988-04-15 Topisk straalebeskyttende gel for mucosa
FI890715A FI890715A (fi) 1986-08-18 1989-02-15 Topikalt, mot straolning skyddande gel foer slemhinnor.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8603481A SE457055B (sv) 1986-08-18 1986-08-18 Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser

Publications (3)

Publication Number Publication Date
SE8603481D0 SE8603481D0 (sv) 1986-08-18
SE8603481L SE8603481L (sv) 1988-02-19
SE457055B true SE457055B (sv) 1988-11-28

Family

ID=20365336

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8603481A SE457055B (sv) 1986-08-18 1986-08-18 Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser

Country Status (11)

Country Link
EP (1) EP0265400B1 (fr)
JP (1) JPH02500668A (fr)
AT (1) ATE64308T1 (fr)
AU (1) AU609417B2 (fr)
DE (1) DE3770753D1 (fr)
DK (1) DK206688A (fr)
FI (1) FI890715A (fr)
IL (1) IL83566A (fr)
NO (1) NO881580L (fr)
SE (1) SE457055B (fr)
WO (1) WO1988001163A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300036A4 (fr) * 1987-01-30 1989-06-14 Biomed Res Consultants Ltd Compositions pharmaceutiques a base de vasopressine.
DE3856315T2 (de) * 1987-10-22 1999-10-14 The Procter & Gamble Co. Chelatbildner enthaltende Lichtschutzmittel
AU744799B2 (en) * 1998-03-10 2002-03-07 University Of Southern California Improved radiation therapy methods
US6455500B1 (en) 1998-03-10 2002-09-24 University Of Southern California Radiation therapy methods
US7173011B2 (en) 2000-11-20 2007-02-06 University Of Southern California Radiation therapy methods
RU2271810C2 (ru) * 2000-10-27 2006-03-20 Лео Фарма А/С Композиции местного применения, содержащие, по меньшей мере, один витамин d или один аналог витамина d и, по меньшей мере, один кортикостероид
JP2006501303A (ja) * 2002-10-01 2006-01-12 ミトス・ファーマシューティカルズ・インコーポレーテッド ニトロキシド放射線防護製剤および使用法
US7183255B2 (en) * 2003-02-26 2007-02-27 Intradialytic Pharmaceuticals Method for stabilizing blood pressure in hemodialysis subjects
JO2937B1 (en) 2004-08-11 2016-03-15 فيرينغ.بي.في Tight muscles of the peptide vascular tensioner receptor
PL2656860T3 (pl) * 2005-06-17 2021-11-08 Wisconsin Alumni Research Foundation Preparaty środka zwężającego naczynia i sposoby ochrony komórek podczas chemioterapii i radioterapii przeciwnowotworowej
US8883965B2 (en) 2006-02-10 2014-11-11 Ferring B.V. Compounds
US9050286B2 (en) 2007-08-14 2015-06-09 Ferring B.V. Use of peptidic vasopression receptor agonists
EP2890361A2 (fr) * 2012-10-16 2015-07-08 Rohm and Haas Company Gels aqueux contenant un émollient

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2785103A (en) * 1953-12-31 1957-03-12 Abbott Lab L-desoxyephedrine inhalant preparation
CH455823A (de) * 1964-08-01 1968-05-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung von Peptiden
JPS52156913A (en) * 1976-06-21 1977-12-27 Toko Yakuhin Kogyo Kk Production of injectionable medicine
DE3106619A1 (de) * 1981-02-23 1982-09-09 Klaus-Dieter Dr. 3550 Marburg Bremecker Pharmazeutische zubereitung in form eines mikroklysmas

Also Published As

Publication number Publication date
SE8603481L (sv) 1988-02-19
EP0265400A2 (fr) 1988-04-27
AU609417B2 (en) 1991-05-02
NO881580D0 (no) 1988-04-12
DK206688D0 (da) 1988-04-15
DE3770753D1 (de) 1991-07-18
FI890715A0 (fi) 1989-02-15
IL83566A0 (en) 1988-01-31
JPH02500668A (ja) 1990-03-08
EP0265400B1 (fr) 1991-06-12
EP0265400A3 (en) 1988-11-09
SE8603481D0 (sv) 1986-08-18
IL83566A (en) 1991-06-10
WO1988001163A1 (fr) 1988-02-25
NO881580L (no) 1988-05-30
ATE64308T1 (de) 1991-06-15
FI890715A (fi) 1989-02-15
AU7852887A (en) 1988-03-08
DK206688A (da) 1988-06-13

Similar Documents

Publication Publication Date Title
SE457055B (sv) Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser
Laschinger et al. Prevention of ischemic spinal cord injury following aortic cross-clamping: use of corticosteroids
Jones et al. Internal cardiac defibrillation in man: pronounced improvement with sequential pulse delivery to two different lead orientations.
Murdock et al. Atrial flutter in patients treated for atrial fibrillation with propafenone
Zalewski et al. Myocardial protection via coronary sinus interventions: superior effects of arterialization compared with intermittent occlusion.
Kerr et al. Suppression of ventricular arrhythmias after coronary artery ligation by pinacidil, a vasodilator drug
Carson et al. Hemodynamic responses initiated by coronary stretch receptors with special reference to coronary arteriography
Elmslie et al. Blocking by spironolactone (SC 9420) of the action of aldosterone upon the intestinal transport of potassium, sodium, and water.
Altura Evidence that endogenous vasopressin plays a protective role in circulatory shock. Role for reticuloendothelial system using Brattleboro rats
Fawaz Effect of reserpine and pronethalol on the therapeutic and toxic actions of digitalis in the dog heart-lung preparation.
Snyder et al. Isolation of sodium as a cause of ventricular fibrillation
Bixler et al. Effects of procaine-induced cardioplegia on myocardial ischemia, myocardial edema, and postarrest ventricular function: a comparison with potassium-induced cardioplegia and hypothermia
Mezaki et al. Discrepancy between inducibility of ventricular tachycardia and activity of cardiac sarcoidosis-Requirement of defibrillator implantation for the inactive stage of cardiac sarcoidosis
Hart et al. Effect of 1-(o-chlorophenyl)-1-(p-chlorophenyl)-2, 2-dichloroethane on adrenocorticotropic hormone-induced steroidogenesis in various preparations in vitro of dog adrenal cortex
Jastremski et al. Femoral venous catheterization during cardiopulmonary resuscitation: a critical appraisal
Schuh Influence of haemodilution on the potency of neuromuscular blocking drugs
Curtis et al. Actions of the verapamil analogues, anipamil and ronipamil, against ischaemia-induced arrhythmias in conscious rats.
Gupta et al. Effects of diphenylhydantoin (Dilantin) on peripheral and coronary circulation and myocardial contractility in the experimental animal
Allen et al. Effects of lignocaine and propranolol on experimental cardiac arrhythmias
Hayton et al. Effect of complex formation on drug absorption XII: Enhancement of intestinal absorption of prednisone and prednisolone by dialkylpropionamides in rats
Wenger et al. Relationship between regional myocardial procainamide concentration and regional myocardial blood flow during ischemia in the dog.
Klöcking et al. Pharmacokinetic studies with 3 H-cytisine
Wilkerson et al. The antiarrhythmic action of amitriptyline on arrhythmias associated with myocardial infarction in dogs
Lynch Jr et al. Failure of lidocaine to suppress lethal ischemic ventricular arrhythmias in a canine model of previous myocardial infarction
RU2371183C2 (ru) Трансдермальные стероидные композиции

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8603481-6

Effective date: 19920306

Format of ref document f/p: F